- Home
- KOPN vs HOWL Comparison
KOPN vs HOWL Comparison
Compare KOPN & HOWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KOPN
- HOWL
- Stock Information
- Founded
- KOPN 1984
- HOWL 2017
- Country
- KOPN United States
- HOWL United States
- Employees
- KOPN N/A
- HOWL N/A
- Industry
- KOPN Semiconductors
- HOWL Biotechnology: Pharmaceutical Preparations
- Sector
- KOPN Technology
- HOWL Health Care
- Exchange
- KOPN Nasdaq
- HOWL Nasdaq
- Market Cap
- KOPN 85.7M
- HOWL 87.4M
- IPO Year
- KOPN 1992
- HOWL 2021
- Fundamental
- Price
- KOPN $0.83
- HOWL $1.77
- Analyst Decision
- KOPN Strong Buy
- HOWL Strong Buy
- Analyst Count
- KOPN 3
- HOWL 2
- Target Price
- KOPN $2.67
- HOWL $13.50
- AVG Volume (30 Days)
- KOPN 1.0M
- HOWL 1.8M
- Earning Date
- KOPN 11-12-2024
- HOWL 11-07-2024
- Dividend Yield
- KOPN N/A
- HOWL N/A
- EPS Growth
- KOPN N/A
- HOWL N/A
- EPS
- KOPN N/A
- HOWL N/A
- Revenue
- KOPN $44,266,305.00
- HOWL $3,386,000.00
- Revenue This Year
- KOPN $22.02
- HOWL N/A
- Revenue Next Year
- KOPN $13.55
- HOWL $191.98
- P/E Ratio
- KOPN N/A
- HOWL N/A
- Revenue Growth
- KOPN 0.60
- HOWL N/A
- 52 Week Low
- KOPN $0.56
- HOWL $1.66
- 52 Week High
- KOPN $2.82
- HOWL $8.19
- Technical
- Relative Strength Index (RSI)
- KOPN 54.06
- HOWL 34.85
- Support Level
- KOPN $0.65
- HOWL $2.19
- Resistance Level
- KOPN $0.92
- HOWL $2.24
- Average True Range (ATR)
- KOPN 0.08
- HOWL 0.20
- MACD
- KOPN 0.01
- HOWL -0.10
- Stochastic Oscillator
- KOPN 66.22
- HOWL 1.24
About KOPN Kopin Corporation
Kopin Corp is a provider of high-performance application-specific optical solutions consisting of high-resolution microdisplays and optics, subassemblies, and headsets. It serves soldiers, avionics, armored vehicles training and simulation military applications, and others. Its product portfolio includes Microdisplays, Spatial Light Modulators, Optical Modules, Medical, Training, and Simulation. Geographically, it derives a majority of its revenue from the Americas and also has a presence in Asia-Pacific; Europe, and Other Countries.
About HOWL Werewolf Therapeutics Inc.
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.